Background: Advances in artificial intelligence and machine learning have facilitated the creation of mortality prediction models which are increasingly used to assess quality of care and inform clinical practice. One open question is whether a hospital should utilize a mortality model trained from a diverse nationwide dataset or use a model developed primarily from their local hospital data.

Objective: To compare performance of a single-hospital, 30-day all-cause mortality model against an established national benchmark on the task of mortality prediction.

Design/participants: We developed a single-hospital mortality prediction model using 9975 consecutive inpatient admissions at the Department of Veterans Affairs Palo Alto Healthcare System from July 26, 2018, to September 30, 2021, and compared performance against an established national model with similar features.

Main Measures: Both the single-hospital model and the national model placed each patient in one of five prediction bins: < 2.5%, 2.5-5%, 5-10%, 10-30%, and ≥ 30% risks of 30-day mortality. Evaluation metrics included receiver operator characteristic area under the curve (ROC AUC), sensitivity, specificity, and balanced accuracy. Final comparisons were made between the single-hospital model trained on the full training set and the national model for both metrics and prediction overlap.

Key Results: With sufficiently large training sets of 2720 or greater inpatient admissions, there was no statistically significant difference between the performances of the national model (ROC AUC 0.89, 95%CI [0.858, 0.919]) and single-hospital model (ROC AUC 0.878, 95%CI [0.84, 0.912]). For the 89 mortality events in the test set, the single-hospital model agreed with the national model risk assessment or an adjacent risk assessment in 92.1% of the encounters.

Conclusions: A single-hospital inpatient mortality prediction model can achieve performance comparable to a national model when evaluated on a single-hospital population, given sufficient sample size.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11606-024-09315-3DOI Listing

Publication Analysis

Top Keywords

mortality prediction
8
mortality model
8
established national
8
national model
8
model
7
mortality
6
comparing single-hospital
4
national
4
single-hospital national
4
national models
4

Similar Publications

Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer.

ESMO Open

January 2025

Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain. Electronic address:

Background: The infiltration of tumor-infiltrating B cells and plasma cells in early-stage breast cancer has been associated with a reduced risk of distant metastasis. However, the influence of B-cell tumor infiltration on overall patient survival remains unclear.

Materials And Methods: This study explored the relationship between an antitumor immune response, measured by a 14-gene B-cell/immunoglobulin (IGG) signature, and mortality risk in 9638 breast cancer patients across three datasets.

View Article and Find Full Text PDF

Background And Aim: Malnutrition is strongly related to mortality in intensive care unit (ICU) patients. The Patient- and Nutrition-Derived Outcome Risk Assessment Score (PANDORA) is a novel mortality prediction tool encompassing nutritional assessment. Since there is limited evidence regarding the power of PANDORA in predicting mortality in critically ill patients, we aimed to evaluate the benefit of adding PANDORA to the Global Leadership Initiative on Malnutrition (GLIM) for mortality prediction in the ICU setting by comparing it with the other valid mortality predictors.

View Article and Find Full Text PDF

Bleeding in patients hospitalized with acute pulmonary embolism in Brazil.

Clinics (Sao Paulo)

January 2025

Division of Emergency Medicine, Department of Internal Medicine, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil. Electronic address:

Objective: Acute Pulmonary Embolism (APE) is a disease with increasing incidence worldwide. Antithrombotics are the cornerstone of the treatment. Bleeding is an adverse event related to this therapy.

View Article and Find Full Text PDF

Dipeptidyl peptidase 4 is a cofactor for porcine epidemic diarrhea virus infection.

Vet Microbiol

January 2025

College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China. Electronic address:

Porcine epidemic diarrhea virus (PEDV) is a member of the genus Alphacoronavirus in the family Coronaviridae, which has a mortality rate of up to 100 % in neonatal piglets and causes huge economic losses to the pig industry. The target cells of PEDV infection are porcine small intestinal epithelial cells, and the mechanism of PEDV invasion remains unclear. Our study found that dipeptidyl peptidase 4 (DPP4) acts as a cofactor for PEDV infection by promoting PEDV invasion and replication.

View Article and Find Full Text PDF

Preeclampsia and eclampsia: Enhanced detection and treatment for morbidity reduction.

Best Pract Res Clin Anaesthesiol

September 2024

Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, L1, Boston, MA, 02115, USA. Electronic address:

Preeclampsia is a life-threatening complication that develops in 2-8% of pregnancies. It is characterized by elevated blood pressure after 20 weeks of gestation and may progress to multiorgan dysfunction, leading to severe maternal and fetal morbidity and mortality. The only definitive treatment is delivery, and efforts are focused on early risk prediction, surveillance, and severity mitigation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!